Abiomed Inc (NASDAQ:ABMD)

184.34
Delayed Data
As of 4:00pm ET
 +6.25 / +3.51%
Today’s Change
155.02
Today|||52-Week Range
364.31
-43.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

2019
Operating ActivitiesNet Income / Starting Line38.1M52.1M112.2M259.0M
 
 
 
 
 
Depreciation3.3M6.2M11.0M14.1M
 
 
 
 
 
Total Other Cash Flow28.7M25.7M45.7M25.6M
 
 
 
 
 
Funds From Operations92.4M109.8M211.5M291.0M
 
 
 
 
 
Funds From/For Other Operating Expenses15.6M-5.3M18.9M38.8M
 
 
 
 
 
Net Cash Flow - Operating Activities76.8M115.1M192.5M252.2M
 
 
 
 
 
 
InvestingIncrease In Investments-261.7M-281.4M-331.8M-404.3M
 
 
 
 
 
Decrease In Investments219.6M205.5M206.9M331.9M
 
 
 
 
 
Capital Expenditures-15.6M-50.4M-55.9M-44.0M
 
 
 
 
 
Net Cash Flow Investing-57.7M-126.3M-180.8M-116.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.00-446.0K-517.0K0.00
 
 
 
Net Proceeds Stock Sale3.6M-7.7M-8.6M-55.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing3.6M12.0M0.000.00
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing7.2M3.9M-9.1M-55.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-415.0K-1.8M1.3M-1.9M
 
 
 
 
 
 
Net Change In Cash26.2M-7.4M2.6M80.0M